Suchergebnisse - "Diver, Sarah"

PubPharm (3)

1

Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma

enthalten in: NEJM evidence | 2023

von Nordenmark, L. | Hellqvist, �. | Emson, C. | +10

2

Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE) : a double-blind, randomised, placebo-controlled, phase 2 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Diver, S. | Khalfaoui, L. | Emson, C. | +10

ErratumIn: Lancet Respir Med. 2021 Nov;9(11):e106. - PMID 34739888

3

CASCADE : a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma

enthalten in: Respiratory research | 2020

von Emson, C. | Diver, S. | Chachi, L. | +7

1
[1]